CLDF Title
Home | Contact Us | Bookmark
HBV HE HCC HCV
About CLDF Centers of Educational Expertise  
CME Dinner Meetings Webcasts Slide Library Abstract Library Conference Highlights
 
Back  
 
Reuters Health Information (2005-05-06): Risk of cognitive impairment high in HCV-HIV coinfection and meth addiction

Epidemiology

Risk of cognitive impairment high in HCV-HIV coinfection and meth addiction

Last Updated: 2005-05-06 15:41:50 -0400 (Reuters Health)

NEW YORK (Reuters Health) - Coinfection with hepatitis C virus (HCV) increases the neuropsychological deficits observed in patients with HIV infection and methamphetamine dependence, according to an article in the April 26th issue of Neurology.

After starting a study of the effects of HIV and meth addiction on cognitive function, Dr. M. Cherner and colleagues at the University of California San Diego found that many of the 430 study participants were also infected with HCV. They therefore investigated the effect of HCV comorbidity on outcomes of neuropsychological testing.

Included were 190 subjects with one of the three risk factors, 110 with two and 40 with three, along with 90 normal control subjects. HCV infection was most prevalent in those who were HIV-positive and methamphetamine-positive (37%) and lowest among those negative for both factors (2%).

The prevalence of global impairment increased with the number of risk factors (p < 0.0001). There were also additive effects on the individual domains of learning, motor speed and dexterity, delayed recall, and abstraction/problem solving.

Linear regression analysis adjusting for demographic factors, methamphetamine dependence and HIV serostatus showed that HCV remained a predictor of global impairment (p < 0.02), learning (p < 0.02), abstraction (p < 0.02), and motor skills (p < 0.04).

The ratio of aspartate aminotransferase to alanine aminotransferase -- a surrogate marker of liver dysfunction -- was not related to deficit scores.

"Because hepatitis C is potentially curable, its identification and treatment are likely to result in improved neurobehavioral outcomes among individuals with HIV infection and substance use disorders," Dr. Cherner's group advises.

"Because the majority of HCV-infected adults have additional risk factors for cognitive impairment such as drug or alcohol abuse or HIV infection, the prevalence of cognitive impairment among these persons may be disconcertingly high," Dr. Wilfred G. van Gorp, at Columbia University in New York, and Dr. Charles H. Hinkin, at the David Geffen School of Medicine at UCLA, point out in a related editorial.

Cognitive impairment can significantly affect employment status, medication adherence, and driving safety, so patients with multiple comorbidities should undergo careful assessment of cognitive function, psychiatric symptoms, and daily functioning, they add.

Neurology 2005;64:1328-1329,1343-1347.

 
 
 
 
                 
 
HBV
Webcasts
Slide Library
Abstract Library
 
HE
CME Dinner Meeting
Webcasts
Slide Library
Abstract Library
 
HCC
Slide Library
Abstract Library
 
 
HCV
Webcasts
Slide Library
Abstract Library
 
CLDF Follow Us
   
 
About CLDF
Mission Statement
Board of Trustees
Board of Advisors
CLDF Supporters
 
Other Resources
Liver News Library
Journal Abstracts
Hep C Link to Care
 
Centers of
Educational Expertise
Regional Map
     
   
  The Chronic Liver Disease Foundation is a non-profit organization with content developed specifically for healthcare professionals.
© Copyright 2012-2014 Chronic Liver Disease Foundation. All rights reserved. This site is maintained as an educational resource for US healthcare providers only.
Use of this Web site is governed by the Chronic Liver Disease Foundation terms of use and privacy statement.